Announcements

Amylyx Pharmaceuticals, Inc. filed a Form 8-K on August 18, 2026, disclosing that it hosted an investor and analyst conference call on that date to discuss positive topline results from the LUCIDITY Phase 3 clinical trial evaluating avexitide in participants with post-bariatric hypoglycemia following …

Universal Technical Institute, Inc. filed a current report on August 18, 2026, disclosing that on August 12, 2026, it entered into a new senior secured revolving credit facility of up to $200 million with Fifth Third Bank as administrative agent and a group of …

Infleqtion, Inc. filed a Form 8-K/A amendment on August 17, 2026, correcting its preliminary financial results for the quarter ended June 30, 2026, after identifying adjustments related to revenue recognition and cost of revenue accounting.

Rexford Industrial Realty, Inc. filed a current report on August 18, 2026, disclosing that its operating partnership entered into an agreement on August 13, 2026, to sell a portfolio of 22 industrial properties to an affiliate of EQT Real Estate for approximately $1.2 billion …

Infleqtion, Inc. (NYSE:INFQ) filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission, reporting on the company's financial condition and operations as an emerging growth company in the quantum computing sector.

Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT), filed a Form 4 on August 17, 2026, disclosing two rounds of stock option exercises and corresponding common stock sales on August 13 and August 17, 2026, pursuant to a previously adopted 10b5-1 …

Gaurav Shah, Chief Executive Officer of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), filed a Form 4 on August 17, 2026, disclosing the sale of 2,837 shares of common stock on August 13, 2026, to cover tax withholding obligations related to the vesting of restricted stock units.